Invention Grant
- Patent Title: FGFR4 antibodies
- Patent Title (中): FGFR4抗体
-
Application No.: US12513448Application Date: 2007-11-02
-
Publication No.: US08394927B2Publication Date: 2013-03-12
- Inventor: Johannes Bange , Jens Niewoehner , Patricia Aus Dem Siepen , Mike Rothe
- Applicant: Johannes Bange , Jens Niewoehner , Patricia Aus Dem Siepen , Mike Rothe
- Applicant Address: DE Martinsried
- Assignee: U3 Pharma GmbH
- Current Assignee: U3 Pharma GmbH
- Current Assignee Address: DE Martinsried
- Agency: Rothwell, Figg, Ernst & Manbeck, P.C.
- Priority: EP06022938 20061103
- International Application: PCT/EP2007/009530 WO 20071102
- International Announcement: WO2008/052796 WO 20080508
- Main IPC: C12P21/08
- IPC: C12P21/08
Abstract:
The present invention relates to FGFR4 antibodies including fragments or derivatives thereof and the polynucleotides encoding the antibodies. Expression vectors and host cells comprising the polynucleotides are provided. Further, the invention refers to pharmaceutical compositions comprising the FGFR4 antibodies and methods for the treatment, prevention or diagnosis of disorders associated with FGFR4 expression.
Public/Granted literature
- US20100169992A1 FGFR4 ANTIBODIES Public/Granted day:2010-07-01
Information query
